Replies to post #78 on Tianyin Pharmaceutical Co., Inc. (TPI)

[surf1944]

5:40AM Tianyin Pharma provides further updates on its GMOL flagship product (TPI) 0.45 : Co provides further updates on the business development of TPI's flagship product: Gingko Mihuan Oral Liquid or GMOL, a prescription medicine that is used by physicians for cardiovascular diseases such as stroke, coronary heart diseases, and angina. GMOL was recently awarded Essential Drug List status in the City of Chongqing. Chongqing, located in southwest China, with a population over 30 mln and its status as the municipality directly under the jurisdiction of the PRC Government along with other major cities with the same status, Beijing, Tianjin and Shanghai which are located in the east coastal area are regarded one of the most attractive markets in pharmaceutical sales in China.